These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 6173420)

  • 21. Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells.
    Welsh RM; Karre K; Hansson M; Kunkel LA; Kiessling RW
    J Immunol; 1981 Jan; 126(1):219-25. PubMed ID: 6161162
    [No Abstract]   [Full Text] [Related]  

  • 22. Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice.
    Baron S; Worthington MG; Williams J; Gaines JW
    Nature; 1976 Jun; 261(5560):505-6. PubMed ID: 180414
    [No Abstract]   [Full Text] [Related]  

  • 23. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM; Wolcott RM; Chervenak R; Jennings SR
    Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additive effects of acyclovir and immune transfer in neonatal herpes simplex virus infection in mice.
    Kohl S
    Infect Immun; 1983 Jan; 39(1):480-2. PubMed ID: 6185435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.
    Starr SE; Visintine AM; Tomeh MO; Nahmias AJ
    Proc Soc Exp Biol Med; 1976 May; 152(1):57-60. PubMed ID: 177992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 protects neonatal mice from lethal herpes simplex virus infection: a macrophage-mediated, gamma interferon-induced mechanism.
    Kohl S; Loo LS; Drath DB; Cox P
    J Infect Dis; 1989 Feb; 159(2):239-47. PubMed ID: 2492588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic assessment of neonatal herpes simplex virus infection in one dizygotic twin.
    Plaeger-Marshall S; Lewis K; Sullivan-Bolyai J; Bryson YJ
    Pediatr Infect Dis J; 1989 Mar; 8(3):171-5. PubMed ID: 2469058
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy of herpes simplex virus infections: a prospective view.
    Schwartz J; Elizan TS
    Mt Sinai J Med; 1973; 40(5):641-51. PubMed ID: 4125976
    [No Abstract]   [Full Text] [Related]  

  • 29. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
    Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
    J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57BL/6) strains of mice.
    Brenner GJ; Cohen N; Moynihan JA
    Cell Immunol; 1994 Sep; 157(2):510-24. PubMed ID: 8069930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fatal case of type 2 herpes simplex virus infection in a newborn.
    Kurata T; Kurata K; Aoyama Y; Hondo R; Yoshino K
    Jpn J Exp Med; 1973 Dec; 43(6):475-82. PubMed ID: 4361509
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus.
    Kohl S
    Rev Infect Dis; 1991; 13 Suppl 11():S950-2. PubMed ID: 1664132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of herpes simplex virus and interferon in human gingival cell cultures.
    Gordon GD; Uhlendorf CP; Baer PN; Baron S
    J Periodontol; 1975 Feb; 46(2):86-9. PubMed ID: 163902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral infection of newborn guinea pigs with herpes simplex virus type 1.
    Blaskovic D; Svobodová J; Weidnerová K; Stastný B
    Acta Virol; 1971 Nov; 15(6):522. PubMed ID: 4400435
    [No Abstract]   [Full Text] [Related]  

  • 35. [Herpes simplex virus and macrophages].
    Scieux C
    Pathol Biol (Paris); 1997 Feb; 45(2):159-64. PubMed ID: 9247038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
    Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice.
    Habu S; Akamatsu K; Tamaoki N; Okumura K
    J Immunol; 1984 Nov; 133(5):2743-7. PubMed ID: 6207244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge.
    Banks TA; Jenkins FJ; Kanangat S; Nair S; Dasgupta S; Foster CM; Rouse BT
    Virology; 1994 Apr; 200(1):236-45. PubMed ID: 8128625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
    Storch E; Baumgartl D; Kirchner H
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic properties of human monocyte-macrophages for human fibroblasts infected in herpes simplex virus: interferon production and augmentation.
    Stanwick TL; Campbell DE; Nahmias AJ
    Cell Immunol; 1982 Jun; 70(1):132-47. PubMed ID: 6180837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.